Wednesday, July 22, 2020 11:40:46 AM
Looks like our mutually agreed schedule has slipped for HGEN
I still think NASDAQ listing is going to happen soon - between 7/24 and 8/7. I don't think it will affect the stock price much. HGEN is already is owned by institutional investors and insiders.
The Phase 3 does not appear to have stopped early from the interim analysis, otherwise the trial enrollment status would have changed by now. That would put the trial enrollment completion to the end of August, 4 weeks to analyze/submit results to FDA, and 2 weeks (minimum) for a emergency use authorization.
Clinical Trial Site Update based on Internet searching:
Active:
-------
Phoenix, Arizona (Mayo Clinic)
Jacksonville, Florida (Mayo Clinic)
Rochester, Minnesota (Mayo Clinic)
Lebanon, New Hampshire (Dartmouth-Hitchcok)
Charlotte, North Carolina (Atrium Health)
Semi-Active:
------------
14 competing therapeutic COVID Clinical Trials ongoing
Atlanta, Georgia (Emory University)
Does Not Appear Active:
-----------------------
No mention of Lenzilumab regarding either of these hospital site.
Dallas, Texas (Texas Health)
Orlando Florida (AdventHealth)
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM